TISSEEL Lyo
Phase 3Completed 0 watching 0 views this week📈 Rising
74
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Adjunct to Hemostasis During Vascular Surgery
Conditions
Adjunct to Hemostasis During Vascular Surgery
Trial Timeline
Jul 10, 2019 → Oct 22, 2019
NCT ID
NCT04083807About TISSEEL Lyo
TISSEEL Lyo is a phase 3 stage product being developed by Baxter for Adjunct to Hemostasis During Vascular Surgery. The current trial status is completed. This product is registered under clinical trial identifier NCT04083807. Target conditions include Adjunct to Hemostasis During Vascular Surgery.
Hype Score Breakdown
Clinical
27
Activity
18
Company
7
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04083807 | Phase 3 | Completed |
Competing Products
4 competing products in Adjunct to Hemostasis During Vascular Surgery
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| FS VH S/D 500 s-apr, 60-seconds polymerization time + FS VH S/D 500 s-apr, 120-seconds polymerization time | Baxter | Phase 2 | 49 |
| Pimavanserin | Acadia Pharmaceuticals | Phase 2 | 47 |
| Pimavanserin | Acadia Pharmaceuticals | Phase 3 | 72 |
| Pimavanserin + Placebo | Acadia Pharmaceuticals | Phase 3 | 72 |